Table 3.
BiVP-CRT | HBP-CRT | LBBAP-CRT | Reference | |
---|---|---|---|---|
Procedural time | lower than HBP higher than LBBAP |
higher than BiVP higher than LBBAP |
lower than BiVP lower than HBP |
[61,62,64,66,69,70,71,73,74] |
Fluoroscopy time | higher than HBP higher than LBBAP |
lower than BiVP comparable to LBBAP |
lower than BiVP comparable to HBP |
[56,60,62,63,68,69,70,71,73,74] |
Acute CS/CSP lead threshold | lower than HBP higher than LBBAP |
higher than BiVP higher than LBBAP | lower than BiVP lower than HBP |
[56,57,58,59,60,61,62,63,65,66,68,69,70,71,72,74] |
Acute haemodynamic effects | worst than HBP worst than LBBAP |
better than BiVP comparable to LBBAP |
better than BiVP comparable to HBP |
[76] |
Paced QRS duration | wider than HBP wider than LBBAP |
narrower than BiVP comparable to LBBAP |
narrower than BiVP comparable to HBP |
[75,76,77] |
Change in LVEF | lower than HBP lower than LBBAP |
greater than BiVP comparable to LBBAP |
greater than BiVP comparable to HBP |
[75,76,77] |
Follow-up CS/CSP lead threshold | lower than HBP higher than LBBAP |
higher than BiVP higher than LBBAP | lower than BiVP lower than HBP |
[56,57,58,59,60,61,62,63,65,66,68,69,70,71,72,74] |
CS/CSP lead-related complications | lower than HBP comparable to LBBAP |
higher than BiVP higher than LBBAP |
comparable to BiVP lower than HBP |
[56,57,58,59,60,61,62,63,64,65,66,68,69,70,71,72,73,74] |
BiVP-CRT: Biventricular pacing cardiac resynchronization therapy; CS: Coronary sinus; CSP: Conduction system pacing; HBP-CRT: His bundle pacing cardiac resynchronization therapy; LBBAP-CRT: Left bundle branch area pacing cardiac resynchronization therapy; LVEF: Left ventricular ejection fraction.